Niraparib: First Global Approval
Year: 2017
Type: article
Source: Drugs
Author: Lesley J. Scott
Institution: Springer Nature (New Zealand)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: niraparib, PARP inhibitors, PARP1, PARP2, maintenance therapy, recurrent epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer, platinum-sensitive ovarian cancer, progression-free survival, germline BRCA mutation, homologous recombination deficiency, drug approval, breast cancer, prostate cancer
Open Access status: closed
OpenAlex ID: W2611848593
